Eisai Co., Ltd.

Eisai Co., Ltd. is a globally recognized pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941, Eisai focuses on the research, development, manufacturing, and marketing of innovative healthcare products. As a distinguished player in the pharmaceutical industry, the company's primary objective is to address unmet medical needs and enhance the health and well-being of patients worldwide. Eisai is particularly noted for its advancements in neuroscience and oncology, with a strong portfolio of treatments targeting Alzheimer's disease, epilepsy, and various types of cancer. Apart from pharmaceuticals, Eisai is also involved in creating generics, diagnostics, and consumer healthcare products. Through its robust R&D framework, Eisai not only contributes to the advancement of medical science but also plays a crucial role in shaping therapeutic landscapes across multiple health sectors and global markets. Its commitment to human health and attention to emerging markets underscore its significance within the global pharmaceutical ecosystem.